Ga-40 a New Immunotherapeutic  &  Anti-cancer Drug - Giorgi Alexidze - Libros - LAP LAMBERT Academic Publishing - 9783659522383 - 12 de febrero de 2014
En caso de que portada y título no coincidan, el título será el correcto

Ga-40 a New Immunotherapeutic & Anti-cancer Drug

Precio
Mex$ 922
sin IVA

Pedido desde almacén remoto

Entrega prevista 14 - 24 de sep.
Recibe notificaciones sobre nuevos lanzamientos de Giorgi Alexidze
Añadir a tu lista de deseos de iMusic

Aún no valorado

The information provided in this book is fully dedicated to new immunotherapeutic and anti-cancer drug GA-40 (plant origin peptide complex). The book is composed of two major parts. The first part of the book (GA-40 in Brief) is targeted for a wide audience. In this part of a book author provide the information about GA-40?s pre-clinical and clinical research results in short and easy to understand conclusions. Author utilized hypothetical schemes to help explain research results and the mechanisms of GA-40 action. This way, the presented material should be easier to understand, interesting, and available to even the readers that have no special scientific background. The second part of the book (Review of GA-40 Scientific Investigation) is strictly scientific. This part of the book describes the results of the GA-40 pre-clinical and clinical trials. It gives information about safety, immunomodulatory, anti-angiogenesis, anti-oxidant, anti-cancer, anti-hepapatitis C, anti-nephritis, anti-tuberculosis, anti-prostatitis, anti- diabet melitus actions of GA-40. The author is convinced that plant peptides in the near future may be a new generation of a safe and highly effective medica

Medios de comunicación Libros     Paperback Book   (Libro con tapa blanda y lomo encolado)
Publicado 12 de febrero de 2014
ISBN13 9783659522383
Editores LAP LAMBERT Academic Publishing
Páginas 588
Dimensiones 150 × 33 × 226 mm   ·   852 g
Lengua Inglés